Is the immunological noise of abnormal autoimmunity an independent risk factor for premature ovarian aging?

Menopause

Volumn 16, Issue 4, 2009, Pages 760-764

  Gleicher, Norbert ^a,b   Weghofer, Andrea ^a,c   Oktay, Kutluk ^a,d   Barad, David H ^a,e  

^a Foundation for Reproductive Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Autoimmunity; FMR1 gene; Fragile X; Ovarian reserve; Premature ovarian aging (POA); Premature ovarian failure (POF)

Indexed keywords

AMIDE; CYSTEINYLGLYCYLGLYCINAMIDE; ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; FEMALE; FEMALE INFERTILITY; FMR1 GENE; GENE; GENETIC ASSOCIATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOISE; PREMATURE OVARIAN FAILURE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TRINUCLEOTIDE REPEAT;

ADULT; ALLELES; AUTOIMMUNITY; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; INFERTILITY, FEMALE; LINEAR MODELS; LOGISTIC MODELS; OVARIAN FAILURE, PREMATURE; RISK FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 68449083917     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e318193c48b     Document Type: Article

References (28)

1. Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod 2003;8:1137-1139.
2. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-606.
3. Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007;109:1404-1410.
4. Gleicher N, Barad D. Unexplained infertility: does it really exist? Hum Reprod 2006;21:1951-1956.
5. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;8:107-134.
6. Wittenberger MD, Hagerman RJ, Sherman SL, et al. The FMR1 premutation and reproduction. Fertil Steril 2007;87:456-465.
7. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-müllerian hormone [published online ahead of print April 1, 2008]. Fertil Steril 2008; doi:10.1016/j.fertnstert. 2008.01.099.
8. Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies [published online ahead of print April 1, 2008]. Fertil Steril 2008; doi:10.1016/j.fertnstert.2008.01.098.
9. Gleicher N, Weghofer A, Oktay K, Barad DH. Can the FMR1 (fragile x) gene serve as a predictor of response to ovarian stimulatiion. RBM online: In press.
10. Gleicher N, El-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. Am J Obstet Gynecol 1989;160:1376-1380; discussion 80-85.
11. Geva E, Amit A, Lerner-Geva L, Lessing JB. Autoimmunity and reproduction. Fertil Steril 1997;67:599-611.
12. Gleicher N. Reproductive failure prior to the onset of clinical autoimmune disease. Rheumatology (Oxford) 1999;38:485-487.
13. Gleicher N, Friberg J. IgM gammopathy and the lupus anticoagulant syndrome in habitual aborters. JAMA 1985;253:3278-3281.
14. Singer T, Barad DH, Weghofer A, Gleicher N. Correlation of anti-müllerian hormone and baseline follicle-stimulating hormone levels [published online ahead of print June 12, 2008]. Fertil Steril 2008; doi:10.1016/j.fernstert.2008.03.034.
15. Galey-Fontaine J, Cedrin-Durnerin I, Chaibi R, Massin N, Hugues JN. Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online 2005;10:94-99.
16. Gleicher N, Vidali A, Karande V. The immunological "Wars of the Roses": disagreements amongst reproductive immunologists. Hum Reprod 2002;17:539-542.
17. Hornstein MD. Antiphospholipid antibodies in patients undergoing IVF: the data do not support testing. Fertil Steril 2000;74:635-636.
18. Hill GA, Scott RJ Jr. Immunologic tests and IVF: "please enough already." Fertil Steril 2000;74:439-442.
19. ASRM Practice Committee Report. Antiphospholipid antibodies do not affect IVF success. Presented at: the American Society for Reproductive Medicine; 2000; AL.
20. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of antiphospholipid antibody syndrome in naïve mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991;88:3069-3073.
21. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001;345:340-350.
22. Shamonki MI, Oktay K. Oocyte and ovarian tissue cryopreservation: indications, techniques, and applications. Semin Reprod Med 2005;23:266-276.
23. Tsigkou A, Marzotti S, Borges L, et al. High serum inhibin concentration discriminates autoimmune oophoritis from other forms of primary ovarian insufficiency. J Clin Endocrinol Metab 2000;93:1263-1269.
24. Burger NZ, Johnson JV. Androgen production in women. In: Androgens and Reproductive Aging. Tulandi T, Gelfand MM, eds. London: Tayler and Francis; 2006; 1-4.
25. Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehy-droepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129-2132.
26. Barad D, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005;84:756.
27. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Rprod 2006;21:2845-2849.
28. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629-634.